Cary J. Claiborne
Overview
Cary J. Claiborne received an average of $761K in total compensation, including $279K in salary, at ADIAL PHARMACEUTICALS from 2021 to 2023. Cary Claiborne also received $314K at Osiris Therapeutics in 2006.
- 2023
- 2022
- 2021
- 2006
ADIAL PHARMACEUTICALSChief Executive Officer and Member of the Board of Directors
ADIAL PHARMACEUTICALSChief Executive Officer and Member of the Board of Directors
ADIAL PHARMACEUTICALSChief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors
Osiris TherapeuticsChief Financial Officer
Source: SEC filings on September 27, 2024, September 29, 2023, September 1, 2022, and April 30, 2007.
Related executives
We found 21 more executives who work or worked at ADIAL PHARMACEUTICALS and Osiris Therapeutics.
Bankole Johnson
ADIAL PHARMACEUTICALS
Chief Medical Officer
Joseph Truluck
ADIAL PHARMACEUTICALS
Chief Financial Officer
William Stilley
ADIAL PHARMACEUTICALS
Chief Executive Officer
Alla Danilkovitch
Osiris Therapeutics
Chief Scientific Officer
Jason Keefer
Osiris Therapeutics
Chief Executive Officer
Linda Palczuk
Osiris Therapeutics
Chief Executive Officer
Linda Chang
Osiris Therapeutics
Chief Financial Officer
David Dresner
Osiris Therapeutics